SynAct Surveys Its Options As Rheumatoid Arthritis Asset Succeeds At Phase II

Partnership Or Acquisition On The Cards

Rheumatoid Arthritis Affects Up To 1% Of The Global Population • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D